The Bottom Line GHK-Cu is the rare peptide where the science actually backs up the hype, at least for its established applications in skin and wound healing
GLP-1 medications are highly regulated they go through years of clinical trials to collect sufficient data on the drugs safety and effectiveness before theyre approved for use
These medications (most frequently levothyroxine) can sometimes trigger side effects, and missing a dose might escalate the symptoms
Intranasal delivery of DSIP would allow targeted treatment in neurodegenerative diseases of the brain
K562 cells were obtained from BCRC (Bioresource Collection and Research Center, Taiwan), and TCCS/KOPM28 from Takeshi Inukai (Department of Pediatrics, School of Medicine, University of Yamanashi, Chuo, Japan)
The first is by prescription from a board-certified medical doctor